ENTRADA THERAPEUTICS, INC. Shares Outstanding (Cover Page)
ENTRADA THERAPEUTICS, INC. (TRDA) had Shares Outstanding (Cover Page) of 38.94 million shares as of 2026-07-31, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-31: Entity Common Stock, Shares Outstanding 38.94M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 38.82M shares.
- 2026-02-19: Entity Common Stock, Shares Outstanding 38.28M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 38.22M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 38.94M shares 10-Q · filed 2026-08-05 |
| 2026-04-30 | 38.82M shares 10-Q · filed 2026-05-07 |
| 2026-02-19 | 38.28M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 38.22M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 38.04M shares 10-Q · filed 2025-08-06 |
| 2025-04-30 | 37.95M shares 10-Q · filed 2025-05-08 |
| 2025-02-20 | 37.59M shares 10-K · filed 2025-02-27 |
| 2024-10-31 | 37.42M shares 10-Q · filed 2024-11-05 |
| 2024-07-31 | 37.20M shares 10-Q · filed 2024-08-13 |
| 2024-04-30 | 33.76M shares 10-Q · filed 2024-05-07 |
| 2024-03-06 | 33.60M shares 10-K · filed 2024-03-13 |
| 2023-10-31 | 33.37M shares 10-Q · filed 2023-11-07 |
| 2023-07-31 | 33.27M shares 10-Q · filed 2023-08-08 |
| 2023-04-30 | 33.20M shares 10-Q/A · filed 2023-08-08 |
| 2023-02-28 | 33.08M shares 10-K/A · filed 2023-08-08 |
| 2022-10-31 | 31.41M shares 10-Q · filed 2022-11-07 |
| 2022-07-31 | 31.37M shares 10-Q · filed 2022-08-11 |
| 2022-04-30 | 31.37M shares 10-Q · filed 2022-05-12 |
| 2022-02-28 | 31.25M shares 10-K · filed 2022-03-15 |
| 2021-11-30 | 31.21M shares 10-Q · filed 2021-12-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |